Navigation Links
Thomson Reuters Honors Temple University Health System for Initiative That Cut Costs $64 Million and Grew Clinical Service Lines
Date:5/14/2008

2008 Insight Awards Recognize Excellence at 13 U.S. Hospitals

ANN ARBOR, Mich., May 14 /PRNewswire-FirstCall/ -- The healthcare business of Thomson Reuters today honored 13 hospitals for excellence in performance improvement at the fourth annual presentation of the Insight Awards. Winners of the 2008 awards were announced during the Thomson Reuters Healthcare Advantage Conference at the Rosen Shingle Creek Resort in Orlando, Florida.

Temple University Health System won the Insight Award for Overall Performance for a multi-year initiative, using Thomson Reuters tools and services including ACTION O-I(R) and Market Expert(R), to reduce costs and increase clinical service line growth.

The health system integrated the ACTION O-I performance benchmarking solution into its operational infrastructure to reduce cost by $64.1 million in the current fiscal year. Simultaneously, it pursued a growth strategy in six clinical service lines using Market Expert strategic planning data to define markets and evaluate competitors for specific services.

The awards were given in four categories: clinical, operational, strategic planning and marketing, and overall performance. The winners are listed below.

Overall Performance

Temple University Health System - Philadelphia, Pa.

Clinical Performance

St. Joseph Medical Centre - Reading, Pa.

St. Tammany Parish Hospital - Covington, La.

Trumbull Memorial Hospital - Warren, Ohio

Clinical Decision Support

Columbus Regional Hospital - Columbus, Ind.

St. Elizabeth Medical Center - Edgewood, Ky.

Nebraska Medical Center - Omaha, Neb.

Operational and Financial

South Jersey Healthcare - Vineland, N.J.

St. Elizabeth Medical Center - Covington, Ky.

Temple University Health System - Philadelphia, Pa.

University Hospital - Augusta, Ga.

Marketing and Planning

Medical Center Hospital - Odessa, Texas


'/>"/>

SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New Thomson Reuters Biomarkers Report Shines a Light on Revolutionary New Area of Drug Development
2. Thomson Healthcare Undertakes Medical Staff Development Project for IASIS Healthcare
3. Thomson Scientific To Honor Australias Top Researchers With Dedicated Australian Research Day
4. Thomson Healthcare Announces Enhancements to Order Sets Solution
5. Thomson Healthcares Clinical Xpert Navigator Tops KLAS Annual Performance Ranking in Mobile Data Systems for Sixth Consecutive Year
6. Thomson Scientific Introduces a New Quarterly Report Identifying the Movers and Shakers in the U.S. Generics Industry
7. Jobson Medical Information LLC Acquires CenterWatch and New England IRB From Thomson Healthcare
8. Saint Barnabas Health Care System Expands Business Relationship with Thomson Healthcare
9. Protalix BioTherapeutics prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific
10. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
11. Thomson Scientific Takes a Fresh Look at Multiauthor Papers
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 1CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 2CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 1Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 2Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 4Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 5Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 1Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 3